Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Open-label, Non-randomized, Single Center Study to Explore Diagnostic Performance of [18F]Fluoroestradiol (FES) Positron Emission Tomography/Computed Tomography for the Assessment of Axillary Lymph Node Metastasis in Estrogen-positive Breast Cancer

NCT06695039 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06695039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06695039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Open-label, Non-randomized, Single Center Study to Explore Diagnostic Performance of [18F]Fluoroestradiol (FES) Positron Emission Tomography/Computed Tomography for the Assessment of Axillary Lymph Node Metastasis in Estrogen-positive Breast Cancer
Lead sponsor
Asan Medical Center
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2024
Completion date
October 2, 2025
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer invasive